Added to YB: 2025-10-20
Pitch date: 2025-10-16
INCY [neutral]
Incyte Corporation
+9.62%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
Market Cap
$20.0B
Pitch Price
$87.04
Price Target
N/A
Dividend
N/A
EV/EBITDA
12.88
P/E
17.29
EV/Sales
3.56
Sector
Biotechnology
Category
N/A
Show full summary:
October 16, 2025 - INCY as the main watch
INCY (watchlist): Biotech consolidating 9 weeks between $82-$88 base. Long entry at $89 breakout, stop at breakout day low. Volatile name capable of big moves, allowing more liberal profit targets. Top watch for Oct 16.
Read full article (1 min)